AnovoRx Holdings LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
AnovoRx Holdings LLC - overview
Established
2012
Location
Memphis, TN, US
Primary Industry
Pharmaceuticals
About
AnovoRx Holdings LLC is a company dedicated to providing comprehensive services for orphan drugs, ensuring improved patient access to treatments for rare diseases through an integrated approach that includes logistics, patient services, and specialty pharmacy. AnovoRx Holdings LLC, founded in 2012 and headquartered in Memphis, US, specializes in solutions for orphan drugs. The firm has completed 2 deals, with the most recent dating back to January 12, 2022. CEO Jon Peters leads the company, which operates independently without subsidiaries or a parent company.
AnovoRx specializes in offering integrated solutions for orphan drugs, focusing on third-party logistics (3PL), patient services (HUB), and specialty pharmacy. Their services are designed to improve patient care and facilitate the commercialization of therapies for rare diseases, with a primary focus on the U. S. market.
AnovoRx generates revenue by providing specialized logistics and patient services to pharmaceutical manufacturers of orphan drugs. Their model includes partnerships where they receive compensation for services tailored to the needs of clients, with performance-based agreements ensuring revenue through established contracts. Following a minority stake investment from TPG in January 2022, AnovoRx plans to use this funding to enhance access to orphan rare disease drugs for patients with complex and chronic conditions. The company is focused on expanding its services and may target new geographic markets, although specific details on new products or regions for expansion have not been disclosed.
Current Investors
Union Main, TPG
Primary Industry
Pharmaceuticals
Sub Industries
Specialty Pharmaceuticals, Pharmaceutical Research & Development, Logistics & Distribution
Website
www.anovorx.com
Verticals
HealthTech
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
AnovoRx Holdings LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | AnovoRx Holdings LLC | - | ||||||||
| Buyout | Completed | AnovoRx Holdings LLC | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.